In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
Inquiry finds price comparison uses wireless carrier’s lowest tier plan but not one of its competitors.
Smartwatches, Smart Rings Marketed to Measure Blood Sugar
FDA warns consumers that devices cannot be trusted to give accurate blood sugar measurements.
Sidebar: Love is a lie
Courthouse News Service
What consumers should know about this purported homeopathic product.